Alx Oncology Holdings Inc (ALXO) posted a -24.77% change over the last five days signaling a new trend

Sana Meer

On Friday, Alx Oncology Holdings Inc (NASDAQ: ALXO) was -15.46% drop from the session before settling in for the closing price of $1.94. A 52-week range for ALXO has been $0.40 – $2.27.

During the last 5-year period, the sales drop of Healthcare Sector giant was -32.29%. When this article was written, the company’s average yearly earnings per share was at 32.69%. With a float of $37.29 million, this company’s outstanding shares have now reached $53.51 million.

Alx Oncology Holdings Inc (ALXO) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Alx Oncology Holdings Inc stocks. The insider ownership of Alx Oncology Holdings Inc is 30.37%, while institutional ownership is 40.34%. The most recent insider transaction that took place on Sep 17 ’25, was worth 76,892. In this transaction CHIEF EXECUTIVE OFFICER of this company bought 71,163 shares at a rate of $1.08, taking the stock ownership to the 305,121 shares. Before that another transaction happened on Sep 16 ’25, when Company’s CHIEF EXECUTIVE OFFICER bought 21,070 for $1.07, making the entire transaction worth $22,461. This insider now owns 233,958 shares in total.

Alx Oncology Holdings Inc (ALXO) Recent Fiscal highlights

Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.58 earnings per share (EPS) during the time that was better than consensus figure (set at -0.66) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 32.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.09% during the next five years compared to -32.29% drop over the previous five years of trading.

Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators

You can see what Alx Oncology Holdings Inc (ALXO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.52.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.20, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.06 in one year’s time.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.